{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:15:33Z","timestamp":1648980933922},"reference-count":35,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:p>CRH is an adrenal androgen secretagogue in men and has been proposed as a candidate regulator of adrenarche. CRH also affects androgen production by theca cells and may be involved in the pathogenesis of ovarian hyperandrogenism (OH). Precocious pubarche (PP) in girls can precede adolescent OH, a condition characterized by a high ovarian 17-hydroxyprogesterone (17-OHP) response 24 h after GnRH agonist challenge.<\/jats:p>\n               <jats:p>In adolescent girls with a history of PP, we assessed the early androgen response to CRH, as well as the CRH effect on the late ovarian response to GnRH agonist.<\/jats:p>\n               <jats:p>Within a randomized cross-over design, saline or CRH (human CRH 1\u03bc g\/kg\u00b7h in saline) was infused over 3-h (1100\u20131400 h) into 12 adolescent girls (age 17 \u00b1 2 yr; body mass index 21.4 \u00b1 0.9 Kg\/m2) who had been pretreated with dexamethasone (1 mg at 0 h) and GnRH agonist (leuprolide acetate 500 \u03bcg sc at 0800 h = time 0). All adolescents had hirsutism, irregular menses, hyperandrogenemia, and hyperinsulinemia after PP. Serum LH, FSH, androstenedione, dehydroepiandrosterone (DHEA), and DHEA-sulfate (DHEAS) were measured at time 0, 3, 6, and 24 h, and ACTH and 17-OHP were measured at time 0, 6, and 24 h.<\/jats:p>\n               <jats:p>ACTH concentrations at the end of saline or CRH infusions were less than 45 pg\/mL; neither saline nor CRH infusions evoked early changes in 17-OHP levels. Within 3 h of CRH infusion, DHEAS increased by 46%, on average; androstenedione increased 2.5-fold and DHEA increased 5-fold during CRH infusion (all P &amp;lt; 0.0001 compared with saline). There was no detectable CRH effect on the responses of LH, FSH, DHEA, DHEAS, 17-OHP, androstenedione, testosterone, and estradiol 24 h after GnRH agonist administration; five of 12 girls had elevated 17-OHP responses suggestive of OH.<\/jats:p>\n               <jats:p>In conclusion, CRH was found to be a potent adrenal androgen secretagogue in adolescent girls with hyperandrogenism after PP. In this study, CRH failed to detectably affect the ovarian androgen response to gonadotropins.<\/jats:p>","DOI":"10.1210\/jcem.84.12.6239","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:03:55Z","timestamp":1389200635000},"page":"4602-4606","source":"Crossref","is-referenced-by-count":1,"title":["Corticotropin-Releasing Hormone: A Potent Androgen Secretagogue in Girls with Hyperandrogenism after Precocious Pubarche1"],"prefix":"10.1210","volume":"84","author":[{"given":"Lourdes","family":"Iba\u0301n\u0303ez","sequence":"first","affiliation":[{"name":"Endocrinology Unit (L.I.), Hospital Sant Joan de De\u0301u, University of Barcelona, 08950 Esplugues, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Potau","sequence":"additional","affiliation":[{"name":"Hormonal Laboratory (N.P.), Hospital Materno-Infantil Vall d\u2019Hebron, Autonomous University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Victoria","family":"Marcos","sequence":"additional","affiliation":[{"name":"Consorci Hospitalari de Terrassa (M.V.M.), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (F.d.Z.), University of Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071620065663600_R1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and \u03b2-endorphin.","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"2020071620065663600_R2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1523\/JNEUROSCI.07-01-00088.1987","article-title":"Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.","volume":"7","year":"1987","journal-title":"J Neurosci"},{"key":"2020071620065663600_R3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1925600","article-title":"Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.","volume":"254","author":"Karalis","year":"1991","journal-title":"Science"},{"key":"2020071620065663600_R4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/endo-127-3-1541","article-title":"Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antirreproductive role in the testis.","volume":"127","author":"Fabbri","year":"1990","journal-title":"Endocrinology"},{"key":"2020071620065663600_R5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1095\/biolreprod53.3.620","article-title":"Corticotropin-releasing hormone stimulates steroidogenesis in mouse Leydig cells.","volume":"53","author":"Huang","year":"1995","journal-title":"Biol Reprod"},{"key":"2020071620065663600_R6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI116672","article-title":"Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.","volume":"92","author":"Mastorakos","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071620065663600_R7","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/endo.137.10.8828472","article-title":"Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro.","volume":"137","author":"Calogero","year":"1996","journal-title":"Endocrinology"},{"key":"2020071620065663600_R8","first-page":"1191","article-title":"Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries.","volume":"79","author":"Mastorakos","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R9","first-page":"2720","article-title":"Expression of genes encoding corticotropin-releasing factor (CRF) type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary.","volume":"82","author":"Asakura","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R10","first-page":"2916","article-title":"Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells.","volume":"83","author":"Smith","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R11","first-page":"448","article-title":"Corticotropin-releasing factor inhibits luteinizing hormone-stimulated P450c17 gene expression and androgen production by isolated thecal cells of human ovarian follicles.","volume":"83","author":"Erden","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R12","author":"Grumbach","year":"1998"},{"key":"2020071620065663600_R13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2265.1997.1580969.x","article-title":"Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche.","volume":"46","author":"Weber","year":"1997","journal-title":"Clin Endocrinol"},{"key":"2020071620065663600_R14","first-page":"3695","article-title":"Adrenarche results from development of a 3\u03b2-hydroxysteroid dehydrogenase-deficient adrenal reticularis.","volume":"83","author":"Gell","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1203\/00006450-199909000-00018","article-title":"Corticotropin-releasing hormone as adrenal androgen secretagogue.","volume":"46","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"Pediatr Res"},{"key":"2020071620065663600_R16","author":"Iba\u0301n\u0303ez","year":"1997"},{"key":"2020071620065663600_R17","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.","volume":"83","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R18","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased incidence of functional ovarian hyperandrogenism.","volume":"76","author":"Iba\u0301n\u0303ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R19","first-page":"2283","article-title":"Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche.","volume":"82","author":"Iba\u0301n\u0303ez","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s001250051030","article-title":"Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.","volume":"41","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"Diabetologia"},{"key":"2020071620065663600_R21","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence.","volume":"84","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/edrv-16-3-322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.","volume":"16","author":"Ehrman","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071620065663600_R23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the diagnosis and classification of diabetes mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"2020071620065663600_R25","first-page":"3320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.","volume":"56","author":"New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R26","first-page":"3961","article-title":"Studies of 3\u03b2-hydroxy- steroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated \u03945-steroid levels.","volume":"81","author":"Sakkal-Alkaddour","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R27","first-page":"1778","article-title":"Source localization of androgen excess in adolescent girls.","volume":"79","author":"Iba\u0301n\u0303ez","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R28","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1210\/jcem.83.10.5315","article-title":"Cortisol, androstenedione (A4), dehydroepiandrosterone sulphate (DHEAS) and 17-hydroxyprogesterone (17-OHP) responses to low doses of (1\u201324) ACTH.","volume":"83","author":"Bridges","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem-73-3-674","article-title":"Normative data for adrenal steroidogenesis in a healthy population: age- and sex-related changes after adrenocorticotropin stimulation.","volume":"73","author":"Lashansky","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/eje.0.1390575","article-title":"The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function.","volume":"139","author":"Ambrosi","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071620065663600_R31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/edrv.19.2.0326","article-title":"Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.","volume":"19","author":"Ehrhart-Bornstein","year":"1998","journal-title":"Endocr Rev"},{"key":"2020071620065663600_R32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1210\/jcem.84.5.5631","article-title":"Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs.","volume":"84","author":"Bornstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/endo-120-3-1083","article-title":"Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.","volume":"120","author":"Petraglia","year":"1987","journal-title":"Endocrinology"},{"key":"2020071620065663600_R34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1210\/jcem-65-2-262","article-title":"Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey.","volume":"65","author":"Olster","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620065663600_R35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jcem-68-3-523","article-title":"Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.","volume":"68","author":"Barbarino","year":"1989","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/12\/4602\/9217544\/jcem4602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/12\/4602\/9217544\/jcem4602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:01:07Z","timestamp":1594962067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/84\/12\/4602\/2864758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.84.12.6239","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}